Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
EyeMarker Systems was a medical technology company focused on developing rapid, non-invasive diagnostic tools for the detection of Traumatic Brain Injury (TBI) and concussions. The company's core technology, the EyeMarker device, utilized advanced eye-tracking and biomarker analysis to assess neurological health at the point of care. By measuring specific ocular responses and pupillary light reflexes, the system aimed to provide objective data to clinicians, athletic trainers, and military personnel for immediate injury assessment. The platform was designed to replace subjective screening methods with a portable, data-driven solution for brain health monitoring. Although the company secured regional investment and academic partnerships, it is currently considered inactive.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on EyeMarker Systems.